ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Trifluoroacetic acid → N-[(5-Chloro-3'-{[(3S)-3-methyl-1-piperazinyl]methyl}-3-biphenylyl)methyl]-N'-{[1,6-diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]methyl}-1,3-benzenedicarboxamide

HRID 564593
ノート
印刷プレビュー

反応式

HRID 564593 の反応式
[CH3:1][C@H:2]1[CH2:7][N:6]([CH2:8][C:9]2[CH:14]=[CH:13][CH:12]=[C:11](B3OC(C)(C)C(C)(C)O3)[CH:10]=2)[CH2:5][CH2:4][N:3]1C(OC(C)(C)C)=O.Br[C:32]1[CH:33]=[C:34]([CH2:39][NH:40][C:41]([C:43]2[CH:48]=[CH:47][CH:46]=[C:45]([C:49]([NH:51][CH2:52][C:53]3[C:54]([NH:66][CH:67]4[CH2:72][CH2:71][O:70][CH2:69][CH2:68]4)=[C:55]4[CH:63]=[N:62][N:61]([CH2:64][CH3:65])[C:56]4=[N:57][C:58]=3[CH2:59][CH3:60])=[O:50])[CH:44]=2)=[O:42])[CH:35]=[C:36]([Cl:38])[CH:37]=1.C(=O)([O-])[O-].[K+].[K+].FC(F)(F)C(O)=O>O1CCOCC1.O.C(Cl)Cl.CS(C)=O.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[Cl:38][C:36]1[CH:35]=[C:34]([CH2:39][NH:40][C:41]([C:43]2[CH:48]=[CH:47][CH:46]=[C:45]([C:49]([NH:51][CH2:52][C:53]3[C:54]([NH:66][CH:67]4[CH2:72][CH2:71][O:70][CH2:69][CH2:68]4)=[C:55]4[CH:63]=[N:62][N:61]([CH2:64][CH3:65])[C:56]4=[N:57][C:58]=3[CH2:59][CH3:60])=[O:50])[CH:44]=2)=[O:42])[CH:33]=[C:32]([C:11]2[CH:12]=[CH:13][CH:14]=[C:9]([CH2:8][N:6]3[CH2:5][CH2:4][NH:3][C@@H:2]([CH3:1])[CH2:7]3)[CH:10]=2)[CH:37]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

10

反応物 4

HCID 6422Trifluoroacetic acidHCID 11430Potassium CarbonateHCID 578132571,1-dimethylethyl (2S)-2-methyl-4-{[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl}-1-piperazinecarboxylateHCID 57813347N-[(3-Bromo-5-chlorophenyl)methyl]-N'-{[1,6-diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]methyl}-1,3-benzenedicarboxamide

生成物 1

HCID 57813491
N-[(5-Chloro-3'-{[(3S)-3-methyl-1-piperazinyl]methyl}-3-biphenylyl)methyl]-N'-{[1,6-diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]methyl}-1,3-benzenedicarboxamide

試薬・触媒・溶媒 5

HCID 178418397HCID 178418397、化合物触媒HCID 679Dimethyl Sulfoxide溶媒HCID 962Water溶媒HCID 6344Dichloromethane溶媒HCID 312751,4-Dioxane溶媒

実験手順

1,1-Dimethylethyl (2S)-2-methyl-4-{[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl}-1-piperazinecarboxylate (24.98 mg, 0.060 mmol), N-[(3-bromo-5-chlorophenyl)methyl]-N′-{[1,6-diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]methyl}-1,3-benzenedicarboxamide (39.2 mg, 0.06 mmol), potassium carbonate (0.025 g, 0.18 mmol), and Pd(Ph3P)4 (3.47 mg, 3.00 μmol) were added to a 0.5-2 mL Biotage microwave vial in 1,4-dioxane (1.5 mL) and water (0.5 mL). The vial was capped and the mixture microwaved at normal power in the SmithCreator microwave at 100° C. for 15 min. LC-MS indicated complete reaction. The crude product was partitioned between EtOAc (30 mL) and water (10 mL). The phases were separated, and the organic washed with brine, dried over anhydrous Na2SO4 filtered and concentrated to give the protected product. This was taken up in DCM (1.8 mL) and treated with trifluoroacetic acid (0.2 mL). The mixture was stirred under argon for 5 h. LC-MS indicated complete reaction. Solvents were pumped off and the residue taken up in DMSO and purified on the Gilson with the TFA system. This was converted to the free base by taking the residue up in EtOAc (30 mL) and 2.5 N NaOH (5 mL). The phases were separated and the organic phase washed with 2.5 N NaOH (3×5 mL) and then with brine (2×5 mL). The organic phase was dried over anhydrous Na2SO4, filtered and concentrated to give the title compound as a white solid. LC-MS m/z 763.1 (M+H)+, 1.67 min (ret time); mp 119-121° C. Analytical HPLC shows 100% purity, (ret time 10.534 min).

後処理

  1. customThe vial was capped
  2. customthe mixture microwaved at normal power in the SmithCreator microwave at 100° C. for 15 min
  3. customreaction
  4. customThe crude product was partitioned between EtOAc (30 mL) and water (10 mL)
  5. customThe phases were separated
  6. washthe organic washed with brine
  7. dry with materialdried over anhydrous Na2SO4
  8. filtrationfiltered
  9. concentrationconcentrated
  10. customto give the protected product
  11. customreaction
  12. custompurified on the Gilson with the TFA system
  13. customThe phases were separated
  14. washthe organic phase washed with 2.5 N NaOH (3×5 mL)
  15. dry with materialThe organic phase was dried over anhydrous Na2SO4
  16. filtrationfiltered
  17. concentrationconcentrated

出典と根拠

ORDレコード
ord-4c7980375e5f4012b9553caf1458e090
出典データセット
uspto-grants-2011_11
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08067408B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート